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THE assessment of cases of carcinoma of the breast has presented considerable
difficulty, both histologically and clinically. Bloom and Richardson (1957)
introduced a system of histological grading which has made it possible to predict
withtolerable accuracy the subsequent clinical progress ofthe patient. Histology,
however, though useful in the initial assessment does not afford a means of
following the day to day progress of patients with metastatic carcinoma, nor of
following their response to treatment. In order to do this a number ofbiochemical
parameters have been measured and correlated with the clinical progress of the
patients. Among these urinary calcium excretion and serum acid and alkaline
phosphatase levels have been widely used. Bodansky (1954) measured the serum
levels ofthe enzyme phosphohexose isomerase in a number ofpatients with meta-
static breast cancer and found that, on the whole, these levels corresponded better
with the clinical state than any other parameter. High levels were found at times
when the metastases were obviously growing rapidly and they returned to normal
when the growth remitted. Bodansky's work suggested that there should be some
correlation between the cellular activity ofthe tumour and its enzyme content.
In carcinoma of the breast, Joplin and Jegatheesen (1962) showed that serum
phosphohexose isomerase was more frequently elevated than the formol stable acid
phosphatase, phosphoglucomutase and the lactic dehydrogenase. Jegatheesen
-andJoplin (1962) showed in amultiple study ofserumenzymes,thatphosphohexose
isomerase and serum acid phosphotase correlated well with the effects ofpituitary
-ablation, and they suggested that these enzymes would be of value in the assess-
ment of these patients. Griffiths and Beck (1963) showed that these enzymes
correlated well with the incidence of secondary deposits. Atkins and his co-
workers (1964) have shown that a discriminant based on steroid excretion studies
can be used to predict the response to hypophysectomy. This is rather beyond
the scope of the peripheral hospital and also cannot give a guide to the develop-
ment of secondary lesions in the subsequent post-operative follow-up.
It might be expected that there should be some correlation between tumour
enzyme content and the Bloom and Richardson grading, particularly ifthe tumour
-was the source of the serum enzyme. Barrett and Gibson (1964) showed that the
amount of isoenzyme 5 of lactic dehydrogenase correlated with the Bloom and
Richardson grading. Jegatheesen (1959) showed that the phosphohexose isomer-
ase content of carcinomata of the breast was raised.
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MATERIALS
Fifty random samples of breast tissue were obtained at operation and im-
mediately processed. If it was not possible to process the material at once, it
was deep frozen with solid carbon dioxide and kept in the deep freeze at -15° C.
METHODS
After weighing and washing the tissue was homogenised in isotonic KCL and
made up to 1/10 dilution of the original tissue. The subsequent preparation
followed that of Glock and McLean (1955). After homogenisation the material
was dialysed overnight at 40 C. against KCI. The homogenate was centrifuged for
one hour at 6000 g at 40 C. and the supernatant was usedforthe assay. The material
was stored at -15 C. The assay used was that ofBodansky (1961). The results
were expressed as micromoles offructose 6 phosphate formed per minute per gram
of breast tissue.
RESULTS
The results are shown in Fig. 1. It will be seen that, with the exception of
fibroadenomas, the other breast conditions appear to have considerably lower tissue
levels than carcinomata. There is undoubtedly some overlap, particularly with
chronic cystic hyperplasia. There is not a very close relationship between the
histological picture and the tumour enzyme content, the overall results for car-
cinoma give a mean of 13-1 + 3-28 ,umoles/min./g. The higher contents were
more often found in the third grade. When the results were analysed against the
menopausal status of the patient no significant difference was noted between the
pre- and post-menopausal groups.
DISCUSSION
It appears that the tissue content of phosphohexose isomerase bears some
relationship to the histological grading of the tumour. The higher enzyme levels
are more common in Grade III than in Grade II, while very low levels are more
common in Grade I neoplasms. It was also of interest that the two mucous
secreting neoplasms had low levels ofphosphohexose isomerase as did one tumour
which showed considerable hyalinisation. With the exception of fibroadenomata
there is a general separation between carcinomata and other benign lesions of the
breast. The overlap between Grade I lesions and chronic cystic hyperplasia is not
surprising as the latter condition may present an exceptionally active histological
picture. The overlap is considerably less when the three tissues with the lowest
levels among the Grade I carcinomata are excluded. These cases were the
two mucous secreting carcinomata and the one tumour showing considerable
hyalinisation. One of the mucous secreting carcinomata was removed from a
patient with hypopituitarism. It is interesting that two of the very high levels
found were in fibroadenomata occurring in pregnant women. One might be
tempted to suggest that pregnancy may be the cause, but it has been shown by
McLean (1958) that in the rat, the phosphohexose isomerase level only increased
at the commencement of lactation. One must conclude that this is the property
of the tumour, since the other fibroadenomata with a high enzyme content was
obtained from a non-pregnant single woman.
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FIG}. 1. Phosphohexose isomerase activity in various conditions.
Red blood cells have relatively high isomerase levels (Bodansky, 1954) and the
contamination of specimens would tend to invalidate the results. Care was taken
to blot the tissue specimens as they were cut in order to remove any blood. The
supernatants did not show any significant discolouration and it was not found that
the anaplastic tumours contained more blood than other tumours. Accordingly
no quantitative allowance has been made for the blood contained in the tissue. It
appears that carcinomatous tissues have higher levels of phosphohexose isomerase
than tissues from other breast lesions. The amount does appear to be related to
the degree of malignancy as assessed by the Bloom and Richardson grading.
SUMMARY
The level of phosphohexose isomerase in carcinomatous breast tissue has been
studied in relationship to the classification of Bloom and Richardson (1957).
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There appeared to be some reasonable correlation, between histological gradilng
anid enzvme contenit.
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